Leading the Way in Life Science Technologies

GEN Exclusives

More »

The Lists

More »
Feb 25, 2013

Top 10 Biopharma Employers with Certified H-1B Workers

Which companies hire the most professionals from overseas?

Top 10 Biopharma Employers with Certified H-1B Workers

Check out GEN's list to find out which biopharma firms are hiring the most professionals from around the globe. [© walex101 - Fotolia.com]

  • Recently, Senators Chris Coons (D-DE), Orrin Hatch (R-UT), Amy Klobuchar (D-MN), and Marco Rubio (R-FL) introduced the Immigration Innovation Act of 2013, a measure that would raise the H-1B cap from the current 65,000 to 115,000 and even higher, under some circumstances. This would raise the current cap on the number of individuals eligible for H-1B visas issued annually to overseas professionals working for biopharmas and other U.S. tech employers. So, who’s actually doing the hiring?

    You’ve already seen the top 10 biopharma layoffs of 2012; now, here are the top 10 biopharma companies with certified H-1B staff, ranked by their numbers of workers certified for employment through the H-1B visa program during federal Fiscal Year 2012, ending September 30, 2012. Also listed for companies are their numbers, if any, of workers denied the visas, and workers who were certified, but whose certifications were later withdrawn.

  • #10. AstraZeneca and subsidiary MedImmune1

    23 workers certified

    1 certified-withdrawn; 1 withdrawn; 1 denied

  • #9. Sanofi (and subsidiary Genzyme)2

    24 workers certified

    2 certified-withdrawn; 1 denied

  • #8. Biogen Idec

    25 workers certified

  • #7. Pfizer

    28 workers certified

    4 certified-withdrawn

  • #6. Merck & Co.

    34 workers certified

    3 denied; one certified-withdrawn; 1 withdrawn

  • #5. Abbott Laboratories

    37 workers certified

    3 denied

  • #4. Amgen

    40 workers certified

    2 certified-withdrawn

  • #3. Roche and subsidiary Genentech3

    41 workers certified

    3 denied; 1 certified-withdrawn

  • #2. Bristol-Myers Squibb

    50 workers certified

    1 certified-withdrawn

  • #1. Novartis4

    62 workers certified

    3 withdrawn; 1 denied

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »